Ghost Tree Capital, LLC Homology Medicines, Inc. Transaction History

Ghost Tree Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $1.2 Million - $1.79 Million	-135,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $994,000 - $1.66 Million	-100,000 Reduced 42.55%	135,000 $1.45 Million
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $422,450 - $676,900	35,000 Added 17.5%	235,000 $3.57 Million
Q1 2020 May 15, 2020	BUY	$12.5 - $22.04 $2.5 Million - $4.41 Million	200,000 New	200,000 $3.11 Million
Q4 2019 Feb 14, 2020	SELL	$11.42 - $22.19 $2.57 Million - $4.99 Million	-225,000 Closed	0 $0

Q3 2019 Nov 14, 2019	BUY	$14.74 - $22.28 $1.47 Million - $2.23 Million	100,000 Added 80.0%	225,000 $4.07 Million
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $2.29 Million - $3.79 Million	125,000 New	125,000 $2.45 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.